Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.2 USD | +0.37% | +4.31% | +20.34% |
Apr. 26 | Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141 | MT |
Apr. 26 | Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128 | MT |
Financials (USD)
Sales 2024 * | 63.98B | Sales 2025 * | 68.37B | Capitalization | 331B |
---|---|---|---|---|---|
Net income 2024 * | 19.47B | Net income 2025 * | 21.89B | EV / Sales 2024 * | 5.48 x |
Net Debt 2024 * | 19.27B | Net Debt 2025 * | 7.68B | EV / Sales 2025 * | 4.96 x |
P/E ratio 2024 * |
16.6
x | P/E ratio 2025 * |
14.6
x | Employees | 71,000 |
Yield 2024 * |
2.32% | Yield 2025 * |
2.47% | Free-Float | 70.75% |
Latest transcript on Merck & Co., Inc.
1 day | +0.37% | ||
1 week | +4.31% | ||
Current month | -0.57% | ||
1 month | +4.53% | ||
3 months | +8.59% | ||
6 months | +24.30% | ||
Current year | +20.34% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 14-03-31 |
Director of Finance/CFO | 55 | 89-12-31 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 07-11-26 |
Pamela Craig
BRD | Director/Board Member | 67 | 15-08-31 |
Inge Thulin
BRD | Director/Board Member | 69 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.34% | 215 M€ | +10.68% | - | |
5.61% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 131.2 | +0.37% | 7,757,297 |
24-04-25 | 130.7 | +2.93% | 12,750,052 |
24-04-24 | 127 | +0.09% | 7,128,300 |
24-04-23 | 126.9 | -0.05% | 7,743,961 |
24-04-22 | 126.9 | +0.92% | 7,805,992 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.34% | 331B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B | |
-11.77% | 143B |
- Stock Market
- Equities
- MRK Stock